Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × Triptorelin Pamoate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 51 Breast Neoplasms 11 Polycystic Ovary Syndrome 9 Infertility 7 Ovarian Hyperstimulation Syndrome 3 Lymphoma 3 Sarcoma, Ewing 2 Sarcoma 2 Prostate Adenocarcinoma 2 Osteosarcoma 2 Neoplasms 2 Uterine Anomalies 1 The Neoadjuvant Therapy 1 Sleep Wake Disorders 1 Salpingitis 1 Salivary Gland Neoplasms 1 Primary Ovarian Insufficiency 1 Pregnancy, Ectopic 1 Neoplasm Metastasis 1 Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1 Myofibroma 1 Metabolic Syndrome 1 Leiomyoma 1 Infertility, Female 1 Hypogonadism 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Helping Behavior 1 Fatty Liver 1 Fatigue 1

Interventions

Cyclophosphamide 179 fludarabine phosphate 107 Etoposide 100 Peripheral Blood Stem Cell Transplantation 91 Filgrastim 83 Mycophenolic Acid 81 Doxorubicin 78 Whole-Body Irradiation 74 Melphalan 73 Brentuximab Vedotin 70 Radiotherapy 69 Tacrolimus 67 fludarabine 64 Busulfan 64 Vinblastine 59 Cyclosporine 58 Rituximab 56 Dacarbazine 49 Gemcitabine 48 Granulocyte Colony-Stimulating Factor 47 Bleomycin 47 Vincristine 43 Antilymphocyte Serum 43 Prednisone 41 Cytarabine 41 Nivolumab 40 Methotrexate 39 Carmustine 34 pembrolizumab 31 Sirolimus 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01764230 2013-01-09

OVARONKO

Masaryk University

Phase NA Completed

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡